azacitidine and isoproterenol

azacitidine has been researched along with isoproterenol in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (50.00)29.6817
2010's4 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Fukuda, K; Hakuno, D; Konishi, F; Makino, S; Manabe, T; Ogawa, S; Suzuki, Y; Tomita, Y; Umezawa, A1
Carpenter, MK; Police, S; Rao, N; Xu, C1
Chen, SA; Chen, YC; Chen, YJ; Chung, CC; Kao, YH; Kuo, CC; Lien, GS1
Chen, ZW; Shi, KH; Tao, H; Xu, SS; Yang, JJ; Zhan, HY; Zhou, X1

Reviews

1 review(s) available for azacitidine and isoproterenol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

7 other study(ies) available for azacitidine and isoproterenol

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Bone marrow-derived regenerated cardiomyocytes (CMG Cells) express functional adrenergic and muscarinic receptors.
    Circulation, 2002, Jan-22, Volume: 105, Issue:3

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Animals; Azacitidine; Bone Marrow Cells; Cell Differentiation; Cells, Cultured; Heart; Heart Rate; Isoproterenol; Myocardial Contraction; Myocardium; Phenylephrine; Receptors, Adrenergic; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta; Receptors, Muscarinic; RNA, Messenger; Signal Transduction; Transcription, Genetic

2002
Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells.
    Circulation research, 2002, Sep-20, Volume: 91, Issue:6

    Topics: 1-Methyl-3-isobutylxanthine; Azacitidine; Cell Differentiation; Cell Size; Decitabine; Diltiazem; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Embryo, Mammalian; Gene Expression Regulation; Humans; Immunohistochemistry; Isoproterenol; Ki-67 Antigen; Myocardium; Myosin Heavy Chains; Phenylephrine; Stem Cells; Time Factors; Tretinoin; Troponin I

2002
Heart failure and angiotensin II modulate atrial Pitx2c promotor methylation.
    Clinical and experimental pharmacology & physiology, 2013, Volume: 40, Issue:6

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Azacitidine; Cell Line, Tumor; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Drug Interactions; Enzyme Inhibitors; Heart Atria; Heart Failure; Homeobox Protein PITX2; Homeodomain Proteins; Isoproterenol; Losartan; Male; Promoter Regions, Genetic; Rats; RNA; Transcription Factors

2013
DNMT3A silencing RASSF1A promotes cardiac fibrosis through upregulation of ERK1/2.
    Toxicology, 2014, Sep-02, Volume: 323

    Topics: Actins; Animals; Animals, Newborn; Azacitidine; Cells, Cultured; Collagen Type I; Collagen Type I, alpha 1 Chain; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methyltransferase 3A; Fibroblasts; Fibrosis; Gene Silencing; Isoproterenol; Male; MAP Kinase Signaling System; Myocardium; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tumor Suppressor Proteins

2014
chemdatabank.com